InforSense Ltd. has announced that it has joined the Affymetrix GeneChip-compatible Applications Program, and that its InforSense GenSense solution, has achieved GeneChip-compatible™ status with the ...
Affymetrix Inc. has announced that the Genetic Association Information Network (GAIN) will use the Genome-Wide Human SNP Array 6.0 for a series of studies designed to identify the genetic causes of ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...
Affymetrix and DNA Link Sign Partnership for Forensic Test Development for Human Identification SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) and DNA Link, Inc., a Korean ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) announced today that it has been selected as the genotyping supplier by the Green Super Rice project coordinated by the Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback